Literature DB >> 16698129

ESPEN Guidelines on Enteral Nutrition: Gastroenterology.

H Lochs1, C Dejong, F Hammarqvist, X Hebuterne, M Leon-Sanz, T Schütz, W van Gemert, A van Gossum, L Valentini, H Lübke, S Bischoff, N Engelmann, P Thul.   

Abstract

Undernutrition as well as specific nutrient deficiencies have been described in patients with Crohn's disease (CD), ulcerative colitis (UC) and short bowel syndrome (SBS). The present guideline gives evidence-based recommendations for the indication, application and type of formula of enteral nutrition (EN) (oral nutritional supplements (ONS) or tube feeding (TF)) in these patients. It was developed in an interdisciplinary consensus-based process in accordance with officially accepted standards and is based on all relevant publications since 1985. ONS and/or TF in addition to normal food is indicated in undernourished patients with CD or CU to improve nutritional status. In active CD EN is the first line therapy in children and should be used as sole therapy in adults mainly when treatment with corticosteroids is not feasible. No significant differences have been shown in the effects of free amino acid, peptide-based and whole protein formulae for TF. In remission ONS is recommended only in steroid dependent patients in CD. In patients with SBS TF should be introduced in the adaptation phase and should be changed with progressing adaptation to ONS in addition to normal food.

Entities:  

Mesh:

Year:  2006        PMID: 16698129     DOI: 10.1016/j.clnu.2006.01.007

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  56 in total

1.  Longer-term outcomes of nutritional management of Crohn's disease in children.

Authors:  B Lambert; D A Lemberg; S T Leach; A S Day
Journal:  Dig Dis Sci       Date:  2012-06-02       Impact factor: 3.199

Review 2.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

Review 3.  Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives.

Authors:  Maki Nakahigashi; Takayuki Yamamoto; Rodolfo Sacco; Hiroyuki Hanai; Fumio Kobayashi
Journal:  Int J Colorectal Dis       Date:  2015-08-15       Impact factor: 2.571

4.  Utilisation of magnets to enhance gastrointestinal endoscopy.

Authors:  Imdadur Rahman; Praful Patel; Philip Boger; Mike Thomson; Nadeem Ahmad Afzal
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

5.  Are we jumping the gun with pharmaconutrition (immunonutrition) in gastrointestinal onoclogical surgery?

Authors:  Emma Jane Osland; Muhammed Ashraf Memon
Journal:  World J Gastrointest Oncol       Date:  2011-09-15

Review 6.  Conventional therapy for Crohn's disease.

Authors:  Carsten Büning; Herbert Lochs
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 7.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

8.  [Techniques and complications in post-interventional and long-term enteral nutrition].

Authors:  J Teichmann; J F Riemann
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

9.  The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.

Authors:  Gregory Podilsky; Markoulina Berger-Gryllaki; Bernard Testa; Thierry Buclin; Michel Roulet; Andre Pannatier
Journal:  Eur J Clin Pharmacol       Date:  2009-02-03       Impact factor: 2.953

Review 10.  Nutritional therapy for active Crohn's disease.

Authors:  Paul-A Smith
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.